Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.

MLA

Andersson, Ken G., et al. “Feasibility of Imaging of Epidermal Growth Factor Receptor Expression with ZEGFR:2377 Affibody Molecule Labeled with 99mTc Using a Peptide-Based Cysteine-Containing Chelator.” International Journal of Oncology, vol. 49, no. 6, Dec. 2016, pp. 2285–93. EBSCOhost, https://doi.org/10.3892/ijo.2016.3721.

APA

Andersson, K. G., Oroujeni, M., Garousi, J., Mitran, B., Ståhl, S., Orlova, A., Löfblom, J., & Tolmachev, V. (2016). Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator. International Journal of Oncology, 49(6), 2285–2293. https://doi.org/10.3892/ijo.2016.3721

Chicago

Andersson, Ken G, Maryam Oroujeni, Javad Garousi, Bogdan Mitran, Stefan Ståhl, Anna Orlova, John Löfblom, and Vladimir Tolmachev. 2016. “Feasibility of Imaging of Epidermal Growth Factor Receptor Expression with ZEGFR:2377 Affibody Molecule Labeled with 99mTc Using a Peptide-Based Cysteine-Containing Chelator.” International Journal of Oncology 49 (6): 2285–93. doi:10.3892/ijo.2016.3721.